» Articles » PMID: 3306318

Citrate and Renal Calculi

Overview
Publisher Karger
Date 1987 Jan 1
PMID 3306318
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Potassium citrate is a new and exciting therapeutic approach which has considerably broadened our capability for the medical control of stone disease. The discussion summarizes the data supporting utility of potassium citrate in the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis ('idiopathic', or secondary to chronic diarrheal syndrome or thiazide therapy) and uric acid lithiasis with or without calcium stones.

Citing Articles

Localization of the calcium-regulated citrate transport process in proximal tubule cells.

Hering-Smith K, Mao W, Schiro F, Coleman-Barnett J, Pajor A, Hamm L Urolithiasis. 2014; 42(3):209-19.

PMID: 24652587 PMC: 4106718. DOI: 10.1007/s00240-014-0653-4.


Lipid peroxidation and antioxidant vitamins in urolithasis.

Kato J, Ruram A, Singh S, Devi S, Devi T, Singh W Indian J Clin Biochem. 2012; 22(1):128-30.

PMID: 23105666 PMC: 3454268. DOI: 10.1007/BF02912895.


The effect of citrate replacement in hypocitraturic cases on the results of SWL: a preliminary prospective randomized study.

Goktas C, Horuz R, Akca O, Cetinel C, Canguven O, Kafkasli A Int Urol Nephrol. 2012; 44(5):1357-62.

PMID: 22581424 DOI: 10.1007/s11255-012-0190-4.


Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.

Garcia-Nieto V, Monge-Zamorano M, Gonzalez-Garcia M, Luis-Yanes M Pediatr Nephrol. 2011; 27(2):261-8.

PMID: 21874585 DOI: 10.1007/s00467-011-1987-6.


Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats.

Vanachayangkul P, Chow N, Khan S, Butterweck V Urol Res. 2010; 39(3):189-95.

PMID: 21069311 PMC: 3663934. DOI: 10.1007/s00240-010-0333-y.